EWA
SLDB icon

EverSource Wealth Advisors’s Solid Biosciences SLDB Stock Holding History

EverSource Wealth Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.83K Sell
283
-234
-45% -$1.77K ﹤0.01% 3570
2026
Q1 		$3.72K Sell
517
-16
-3% -$103 ﹤0.01% 3400
2025
Q4 		$3.01K Hold
533
– – ﹤0.01% 3336
2025
Q3 		$3.29K Hold
533
– – ﹤0.01% 3331
2025
Q2 		$2.6K Buy
533
+157
+42% +$555 ﹤0.01% 3417
2025
Q1 		$1.39K Buy
+376
New +$1.61K ﹤0.01% 3098

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EverSource Wealth Advisors's SLDB Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Solid Biosciences (SLDB) stake by 45% in Q2 2026, selling an estimated $1.77K and leaving 283 shares worth $2.83K. The position accounts for ﹤0.01% of the portfolio, ranked #3570.

EverSource Wealth Advisors first reported a position in SLDB in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.72K in Q1 2026. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • EverSource Wealth Advisors held 283 shares of Solid Biosciences worth $2.83K as of Q2 2026.
  • EverSource Wealth Advisors sold 234 Solid Biosciences shares in Q2 2026, an estimated $1.77K.
  • Solid Biosciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3570 holding.
  • EverSource Wealth Advisors first reported a position in Solid Biosciences in Q1 2025 and has held it in 6 quarters since.
  • EverSource Wealth Advisors's Solid Biosciences position peaked at $3.72K in Q1 2026.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.